SBL-3 Clinical Data Results Discussion At ASCRS
Drs. Chu, Whitsett, and Loden were speaking of the SBL-3 Clinical Data results during the ASCRS in Las Vegas.
Read More
Softec HD Lens Implanted In Young Patient With Soft Cataract
Dr. Justin Spaulding, who implants our Softec HD Lenses, using our Softec HD in a young patient with soft cataracts.
Read More
Lenstec Submits SBL3 IOL For Pre-Market Approval
St. Petersburg, FL. March 16, 2020 Lenstec Inc. has announced its submission of the SBL- 3 IOL for Pre – Market Approval in the U.S. The Lenstec SBL – 3 IOL (Segmented Bi-Focal Lens) is an asymmetric multifocal refractive IOL utilizing a 3 diopter add with a transition zone connecting the distance and near segments….
Read More
Lenstec Completes FDA Trials Of SBL-3
Lenstec announced that it has completed its FDA trial for the SBL-3 IOL (Segmented Bifocal Lens), an asymmetric multifocal refractive IOL designed to provide patients with superior near, intermediate, and distance vision. It also offers improved contrast sensitivity and minimizes halos and glare (dsyphotopsias) commonly associated with other traditional multifocal-presbyopia correcting IOLs, according to a…
Read More
Lenstec Inc. Has Announced That It Has Completed Enrollment Of The FDA Trial For The SBL-3 IOL.
Lenstec Inc. has announced that it has completed enrollment of the FDA trial for the SBL-3 IOL.The Lenstec SBL – 3 IOL (Segmented Bi Focal Lens) is a non-concentric asymmetric multifocal refractive IOL. It provides patients with superior near, intermediate and distance vision. It also improves contrast sensitivity, and minimizes the halos and glare, (dsyphotopsias)…
Read More
Custom Vision Upgrade With The Softec HD IOL
Neel R. Desai, MD, explains how the Softec HD IOL (Lenstec) benefits his practice. He describes the outcome-based conversations he has with patients about this lens and shares specific pearls for implanting this lens.
Read More
Lenstec And Oculentis Settle Legal Dispute Over Patents For Bifocal IOLs
Lenstec has stated that it has won its UK patent suit against Oculentis for bifocal IOLs. Oculentis has withdrawn legal proceedings against Lenstec in the UK High Court and made a payment towards Lenstec’s legal costs, according to a Lenstec news release. Lenstec has agreed not to pursue Oculentis for any additional costs in what…
Read More